Biocorp
Private Company
Total funding raised: $75M
Overview
Biocorp is a privately-held, integrated developer and manufacturer of connected drug delivery devices and digital health solutions. The company leverages a unique heritage in industrial plastics processing (plasturgy) combined with advanced digital innovation to create customized, connected medical devices. It controls the entire value chain from R&D to final packaging, employing over 100 people across two sites in France. Biocorp operates in a high-growth segment, aiming to enhance treatment adherence and data collection for injectable therapies.
Technology Platform
Integrated platform combining precision plastics engineering for drug delivery devices (pens, syringes) with digital connectivity (sensors, Bluetooth, software apps, cloud data) to create smart, connected medical devices for adherence monitoring and data collection.
Funding History
6Opportunities
Risk Factors
Competitive Landscape
Biocorp competes in the connected drug delivery space against large device OEMs (e.g., Ypsomed, BD, Embecta), digital health startups, and tech companies moving into healthcare. Its differentiation lies in its hybrid model of deep manufacturing expertise combined with digital innovation, and its flexible 'add-on' Mallya system that can retrofit existing pens.